ArticleInternational journal of critical illness and injury science

What's New in Critical Illness and Injury Science? Mortality effects of tocilizumab for patients admitted with COVID-19 pneumonia.

Andrew C Miller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.